World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
110
Citations
38205
World Ranking
510
National Ranking
309

Arnold S. Monto publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Arnold S. Monto sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 405 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Arnold S. Monto D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Arnold S. Monto sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 110 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2009 - Alexander Fleming Award, Infectious Diseases Society of America

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Virus
  • Disease

Arnold S. Monto mainly focuses on Virology, Immunology, Vaccination, Virus and Internal medicine. His study looks at the relationship between Virology and topics such as Oseltamivir, which overlap with Viral shedding. As part of his studies on Immunology, Arnold S. Monto often connects relevant subjects like Disease.

The Vaccination study combines topics in areas such as Environmental health, Immunization and Antigenic drift. Arnold S. Monto interconnects Antibody and Serology in the investigation of issues within Virus. His Internal medicine research incorporates themes from Influenzavirus B, Placebo and Gastroenterology.

His most cited work include:

  • Textbook of Influenza (649 citations)
  • Clinical signs and symptoms predicting influenza infection. (556 citations)
  • The Economic Burden of Non–Influenza-Related Viral Respiratory Tract Infection in the United States (546 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Virology, Vaccination, Immunology, Influenza vaccine and Virus. His Virology research focuses on subjects like Antibody, which are linked to Antigen. His Vaccination research is multidisciplinary, relying on both Influenza a, Pandemic, Pediatrics and Confidence interval.

His Immunology study combines topics from a wide range of disciplines, such as Internal medicine, Epidemiology and Respiratory tract infections. His work focuses on many connections between Influenza vaccine and other disciplines, such as Cohort, that overlap with his field of interest in Cohort study. His research in Virus intersects with topics in Immunization and Microbiology.

He most often published in these fields:

  • Virology (36.50%)
  • Vaccination (33.25%)
  • Immunology (28.75%)

What were the highlights of his more recent work (between 2015-2021)?

  • Influenza vaccine (28.00%)
  • Vaccination (33.25%)
  • Virology (36.50%)

In recent papers he was focusing on the following fields of study:

Influenza vaccine, Vaccination, Virology, Virus and Internal medicine are his primary areas of study. His Influenza vaccine research incorporates elements of Respiratory tract infections, Cohort study, Confidence interval, Influenza a and Cohort. His research in Vaccination intersects with topics in Influenza A virus, Pediatrics, Confounding and Medical record.

As a part of the same scientific family, Arnold S. Monto mostly works in the field of Virology, focusing on Antibody and, on occasion, Antigen and Vaccine strain. His Virus study combines topics from a wide range of disciplines, such as Young adult, Host, Immunization and Transmission. In his research on the topic of Internal medicine, Rhinovirus and Coronavirus is strongly related with Nose.

Between 2015 and 2021, his most popular works were:

  • 2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. (157 citations)
  • Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020. (151 citations)
  • Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013–2014 in the United States (127 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Virus
  • Disease

Arnold S. Monto focuses on Influenza vaccine, Vaccination, Virus, Virology and Confidence interval. His studies in Influenza vaccine integrate themes in fields like Internal medicine, Pandemic and Respiratory tract infections. The Vaccination study combines topics in areas such as Young adult, Influenza a, Influenza A virus, Antigenic drift and Pediatrics.

His Influenza A virus study is focused on Immunology in general. His research integrates issues of Infectious disease, Serology, H5N1 genetic structure and Evolutionary biology in his study of Virus. His research combines Antibody and Virology.

Best Publications

  • The Economic Burden of Non–Influenza-Related Viral Respiratory Tract Infection in the United States

    A. Mark Fendrick;Arnold S. Monto;Brian Nightengale;Matthew Sarnes

  • Clinical signs and symptoms predicting influenza infection.

    Arnold S. Monto;Stefan Gravenstein;Michael Elliott;Michael Colopy

  • Textbook of Influenza

    Robert G. Webster;Arnold S. Monto;Thomas J. Braciale;Robert A. Lamb.

  • Epidemiology of viral respiratory infections

    Arnold S. Monto

  • Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials

    Joanna Dobson;Richard J Whitley;Stuart Pocock;Arnold S Monto

  • Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

    Mark W Tenforde;Wesley H Self;Katherine Adams;Manjusha Gaglani

  • Acute respiratory illness in the community. Frequency of illness and the agents involved.

    A. S. Monto;K. M. Sullivan

  • Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts: A Randomized Controlled Trial

    Robert Welliver;Arnold S. Monto;Otmar Carewicz;Edwig Schatteman

  • Acute Respiratory Illness in an American Community. The Tecumseh Study

    Arnold S. Monto;Betty M. Ullman

  • Inhaled zanamivir for the prevention of influenza in families

    Frederick G. Hayden;Larisa V. Gubareva;Arnold S. Monto;Thomas C. Klein

  • Mask use, hand hygiene, and seasonal influenza-like illness among young adults: A randomized intervention trial

    Allison E. Aiello;Genevra F. Murray;Vanessa Perez;Rebecca M. Coulborn

  • Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use

    Arnold S. Monto;Jennifer L. McKimm-Breschkin;Catherine Macken;Alan W. Hampson

  • Modification of an Outbreak of Influenza in Tecumseh, Michigan by Vaccination of Schoolchildren

    Arnold S. Monto;Fred M. Davenport;John A. Napier;Thomas Francis

  • ESTIMATING HOUSEHOLD AND COMMUNITY TRANSMISSION PARAMETERS FOR INFLUENZA

    Ira M. Longini;James S. Koopman;Arnold S Monto;John P. Fox

  • Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.

    AS Monto;DP Robinson;ML Herlocher;Jr Jm Hinson

  • Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.

    Wesley H. Self;Mark W. Tenforde;Jillian P. Rhoads;Manjusha Gaglani;Manjusha Gaglani

  • Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on Estimates

    Suzanne E. Ohmit;Mark G. Thompson;Joshua G. Petrie;Swathi N. Thaker

  • Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets.

    M. Louise Herlocher;Rachel Truscon;Stephanie Elias;Hui-Ling Yen

  • Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenza A and B Virus Infections

    A. S. Monto;D. M. Fleming;D. Henry;R. de Groot

  • Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020.

    Ranawaka A.P.M. Perera;Chris K.P. Mok;Owen T.Y. Tsang;Huibin Lv

  • Comparative Efficacy of Inactivated and Live Attenuated Influenza Vaccines

    Arnold S. Monto;Suzanne E. Ohmit;Joshua G. Petrie;Emileigh Johnson

  • Prevention of Antigenically Drifted Influenza by Inactivated and Live Attenuated Vaccines

    Suzanne E. Ohmit;John C. Victor;Judy R. Rotthoff;Esther R. Teich

  • TECUMSEH STUDY OF ILLNESS. XIII. INFLUENZA INFECTION AND DISEASE, 1976–1981

    Arnold S. Monto;James S. Koopman;Ira M. Longini

  • THE TECUMSEH STUDY OF RESPIRATORY ILLNESS IX. OCCURRENCE OF INFLUENZA IN THE COMMUNITY, 1966–1971

    Arnold S. Monto;Farideh Kioumehr

  • Effectiveness of Oseltamivir in Preventing Influenza in Household Contacts

    Robert Welliver;Arnold S. Monto;Otmar Carewicz;Edwig Schatteman

  • Zanamivir in the Prevention of Influenza Among Healthy Adults

    Arnold S. Monto;D. Paul Robinson;M. Louise Herlocher;Michael J. Elliott

Frequent Co-Authors

Emily T. Martin
Emily T. Martin University of Michigan–Ann Arbor
Manjusha Gaglani
Manjusha Gaglani Baylor College of Medicine
Richard K. Zimmerman
Richard K. Zimmerman University of Pittsburgh
Suzanne E. Ohmit
Suzanne E. Ohmit University of Michigan–Ann Arbor
Brendan Flannery
Brendan Flannery Centers for Disease Control and Prevention
Edward A. Belongia
Edward A. Belongia Marshfield Clinic
Alicia M. Fry
Alicia M. Fry Emory University
Lisa A. Jackson
Lisa A. Jackson Kaiser Permanente
Huong Q. McLean
Huong Q. McLean Marshfield Clinic
Mary Patricia Nowalk
Mary Patricia Nowalk University of Pittsburgh

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding into related healthcare fields can open diverse career opportunities. Many aspiring healthcare professionals pursue advanced practice degrees, such as psychiatric mental health nurse practitioner programs. Those looking for flexibility and quality clinical experience might explore the best psychiatric mental health nurse practitioner programs online, which emphasize strong clinical placement rates to ensure real-world readiness.

Cost is a significant consideration when selecting an online program. Fortunately, there are several affordable options available, highlighted in the list of affordable pmhnp programs, making advanced education more accessible for many students.

Understanding potential earnings is crucial for career planning. Those pursuing a Doctor of Nursing Practice (DNP) degree can evaluate salaries based on their location by referring to the dnp salary by state. This insight helps in making informed decisions about where to study or work.

Additionally, professionals currently certified as Family Nurse Practitioners (FNP) can broaden their scope by obtaining acute care certification. This transition, detailed in acute care certification for fnp, allows for specialization in acute patient care, complementing foundational knowledge gained through immunology studies.

Best Scientists Citing Arnold S. Monto

Trending Scientists

Recently Published Articles